In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells

Transplantation

Volumn 64, Issue 12, 1997, Pages 1684-1688

  Yu, Samuel ^a   Nakafusa, Yuji ^a   Flye, M Wayne ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GADOLINIUM CHLORIDE; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HELPER CELL; IMMUNOLOGICAL TOLERANCE; KUPFFER CELL; MALE; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PHAGOCYTOSIS; PORTAL VEIN; PRIORITY JOURNAL; RAT; SPLEEN CELL; ULTRAVIOLET B RADIATION; XENOTRANSPLANTATION;

ANIMALS; CELL SEPARATION; GADOLINIUM; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERLEUKIN-2; KUPFFER CELLS; LIVER; LIVER CIRCULATION; LYMPHOCYTE CULTURE TEST, MIXED; RATS; RATS, INBRED BN; RATS, INBRED BUF; RATS, INBRED LEW; SPLEEN;

EID: 0031434849     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00009     Document Type: Conference Paper

References (27)

1. Cantor HM, Dumont AE. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967; 215: 744.
2. Qian JH, Kokudo S, Sato S, Hamoaka T, Fujiwara H. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. Transplantation 1987; 43: 538.
3. Qian JH, Hashmoto T, Fujiwara H, Hamoaka T. Studies on induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 1985; 134: 3656.
4. Kamei T, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. Surgery 1990; 108: 415.
5. Callery MP, Kamei T, Flye MW. The anatomic site-specificity of tolerance induction to alloantigen. Transplantation 1990; 49: 230.
6. Yoshimura N, Hamashima T, Matsui S, Oka T. Prolongation of rat renal allograft survival by portal venous inoculation with donor lymphocytes. Transplant Proc 1989; 21: 3268.
7. Lowry RP, Kenick S, Lisbona R. Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells. Transplant Proc 1987; 19: 3451.
8. Yu S, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 1994; 116: 229.
9. Sano S, Suda T, Qian JH, et al. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells. J Immunol 1987; 139: 3652.
10. Gundlach M, Oluwole SF, D'Agati V, Supe D, Jin M-X, Hardy MA. Differential effects of pretreatment with ultraviolet-B modified or unmodified donor-specific leukocyte transfusions on intestinal and cardiac allograft survival in the rat. Transplantation 1992; 53: 613.
11. Lazar G. The reticuloendothelial blocking effect of rare earth metals in rats. J Reticuloendothelial Soc 1973; 13: 231.
12. Husztik E, Lazar G, Parducz A. Electron microscopic study of Kupffer cell phagocytosis blockade induced by gadolinium chloride. Br J Exp Pathol 1980; 61: 624.
13. Kamei T, Callery MP, Flye MW. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990; 48: 393.
14. Squiers EC, Salomon DR, Pickard LL, Howard RR, Pfaff WW. Abrogation of the induction of portal venous tolerance in a cardiac transplant model resulting from Kupffer cell inhibition by gadolinium. Transplantation 1990; 50: 171.
15. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614.
16. Gallimore PH. Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA in nine lines of transformed rat cells using specific fragments of the viral genome. J Mol Biol 1974; 89: 49.
17. Bellgrau D. Induction of cytotoxic T cell precursors in vivo role of T helper cells. J Exp Med 1983; 157: 1505.
18. Callery MP, Kamei T, Flye MW. Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989; 47: 1092.
19. Sato K, Yabuki K, Haba T, Maekawa T. Role of Kupffer cells in the induction of tolerance after liver transplantation. J Surg Res 1996; 63: 433.
20. Roland CR, Mangino MJ, Duffy BF, Flye MW. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium. Transplantation 1993; 55: 1151.
21. Callery MP, Mangino MJ, Flye MW. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells: a basis of portal venous tolerance. Transplantation 1991; 51: 1076.
22. Roland CR, Mangino MJ, Flye MW. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J Surg Res 1993; 54: 401.
23. Heidecke CD, Kupiec-Weglinski JW, Lear PA, et al. Interaction between T lymphocyte subsets supported by interleukin-2-rich lymphokines produce acute rejection of vasculated cardiac allografts in T cell deprived rats. J Immunol 1984; 133: 582.
24. Lafferty KJ, Cuningham AL. A new analysis of allogeneic interaction. Aust J Exp Biol Med Sci 1975; 53: 27.
25. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. Molecular events in the induction of a non-responsive state in interleukin-2 producing helper T lymphocyte clone. Proc Natl Acad Sci USA 1987; 84: 5409.
26. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169: 1042.
27. Mueller DL, Jenkins MK, Schwartz RH. An accessory cell-mediated costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J Immunol 1989; 142: 2617.